As mentioned above, ADAMTS9-AS2 overexpression and miR-27a-3p knockdown contribute to the inhibition of ccRCC cell proliferation and chemoresistance. This evidence concerns the gene ADAMTS9 and nonpapillary renal cell carcinoma.